Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03148093 · ClinicalTrials.gov registry record
The CHOICE Registry
A clinical trial, sponsored by Taiho Oncology.
- Terminated
- Registry status
- 12
- Enrollment target
NCT03148093: Clinical Trial study, sponsored by Taiho Oncology.
NCT03148093 is a clinical trial that was terminated before completion, run by Taiho Oncology. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03148093 was terminated before completion, sponsored by Taiho Oncology.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The CHOICE Registry will describe real-world treatment patterns and physician and patient (and caregiver)-reported outcomes associated with patients who have progressed beyond 2nd line metastatic colorectal cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2017-12-13 |
Why NCT03148093 stopped before completion
NCT03148093 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03148093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03148093 about?
NCT03148093 is a clinical study titled "The CHOICE Registry". The CHOICE Registry will describe real-world treatment patterns and physician and patient (and caregiver)-reported outcomes associated with patients who have progressed beyond 2nd line metastatic colorectal cancer.
What is the current status of trial NCT03148093?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2017-06-30. Estimated completion is 2017-12-13.
Who is sponsoring clinical trial NCT03148093?
This trial is sponsored by Taiho Oncology, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI